These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2327184)

  • 1. [Detection of Leu-M1 immunoreactivity in brain tissue and brain tumors].
    Szymas J; Hossmann KA; Weber F; Oschlies U
    Zentralbl Allg Pathol; 1990; 136(1-2):171-9. PubMed ID: 2327184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
    Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
    Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia-specific antigen in the intracranial tumors. Immunofluorescence study.
    Lach B; Weinrauder H
    Acta Neuropathol; 1978 Jan; 41(1):9-15. PubMed ID: 345726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrastructural and histochemical characteristics of the degree of malignancy of brain tumors].
    Romodanov AP; Tushevskiĭ VF; Brodskaia IA
    Vestn Akad Med Nauk SSSR; 1977; (10):34-9. PubMed ID: 919747
    [No Abstract]   [Full Text] [Related]  

  • 5. Astrocytes in brain tumours. Differentiation or trapping?
    Escalone Zapata J
    Histol Histopathol; 1994 Apr; 9(2):325-32. PubMed ID: 8075493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of glial fibrillary acid protein in brain tumors by the immunoperoxidase method].
    Bozóky B; Ormos J; Bodosi M
    Morphol Igazsagugyi Orv Sz; 1986 Jul; 26(3):173-9. PubMed ID: 3526137
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical detection of dUTPase in intracranial tumors.
    Romeike BF; Böckeler A; Kremmer E; Sommer P; Krick C; Grässer F
    Pathol Res Pract; 2005; 201(11):727-32. PubMed ID: 16325515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological, immunocytochemical and biological characteristics of experimental rabbit brain tumors in tissue culture.
    Stavrou D; Zänker K; Anzil AP
    J Neurol Sci; 1979 Aug; 42(3):365-79. PubMed ID: 229201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological features of gliomas in children.
    Hirato J; Nakazato Y
    Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A simple method for the isolation of GFAP and its use for the study of brain tumors].
    Fischer W; Heller T; Herrmann E; Schreiber D
    Zentralbl Allg Pathol; 1989; 135(1):33-41. PubMed ID: 2929182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
    Lauro GM; Grossi M; Di Lorenzo N
    Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural characteristics of glial fibrillary acidic protein expression in epoxy resin-embedded human brain tumors.
    Bozóky B; Krenács T; Rázga Z; Erdös A
    Acta Neuropathol; 1993; 86(3):295-301. PubMed ID: 8213089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial and melanoma antigens in gliosarcoma. An immunohistochemical study.
    Gottschalk J; Jautzke G; Schreiner C
    Pathol Res Pract; 1992 Feb; 188(1-2):182-90. PubMed ID: 1594490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
    Li J; Pearl DK; Pfeiffer SE; Yates AJ
    J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor in human brain tumors.
    Di Carlo A; Mariano A; Macchia PE; Moroni MC; Beguinot L; Macchia V
    J Endocrinol Invest; 1992 Jan; 15(1):31-7. PubMed ID: 1560188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural analysis of ependymoastrocytoma histogenesis].
    Romodanov AP; Kop'ev OV; Tushevskiĭ VF
    Zh Vopr Neirokhir Im N N Burdenko; 1978; (6):3-8. PubMed ID: 735605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.